JP2004500353A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004500353A5 JP2004500353A5 JP2001541503A JP2001541503A JP2004500353A5 JP 2004500353 A5 JP2004500353 A5 JP 2004500353A5 JP 2001541503 A JP2001541503 A JP 2001541503A JP 2001541503 A JP2001541503 A JP 2001541503A JP 2004500353 A5 JP2004500353 A5 JP 2004500353A5
- Authority
- JP
- Japan
- Prior art keywords
- drug
- agent
- medicament
- hair
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 6
- 229940079593 drugs Drugs 0.000 description 5
- 229960003987 Melatonin Drugs 0.000 description 2
- 201000004384 alopecia Diseases 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 230000001684 chronic Effects 0.000 description 2
- 230000003695 hair diameter Effects 0.000 description 2
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 2
- 206010068168 Androgenetic alopecia Diseases 0.000 description 1
- 241000246358 Thymus Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000003797 telogen phase Effects 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 230000000699 topical Effects 0.000 description 1
Description
【特許請求の範囲】
【請求項１】 女性型のアンドロゲン性脱毛症およびび慢性脱毛症を治療するためのメラトニン含有薬剤、但し、薬剤はジャコウソウエキスを含まないものとする。
【請求項２】 薬剤が局所適用可能である、請求項１に記載の薬剤。
【請求項３】 薬剤が、噴霧液、溶液、ローション剤、クリームまたは軟膏剤として適用可能である、請求項１または２に記載の薬剤。
【請求項４】 メラトニン製剤が、０．００１〜１％（重量／重量）の作用物質濃度を示す、請求項１から３までのいずれか１項に記載の薬剤。
【請求項５】 薬剤の日用量が、一日当たり０．０１〜１０ｍｇの有効量を含有する、請求項１から４までのいずれか１項に記載の薬剤。
【請求項６】 休止期の割合の減少を達成する、請求項１から５までのいずれか１項に記載の薬剤。
【請求項７】 成長期の割合の増加を達成する、請求項１から６までのいずれか１項に記載の薬剤。
【請求項８】 毛髪直径の増加および／または毛髪の引裂き力の増加が達成される、請求項１から７までのいずれか１項に記載の薬剤。
【請求項９】 び慢性脱毛症において、毛髪直径を増加させ、および／または伸長能力を増加させるためのメラトニン含有薬剤、但し、薬剤はジャコウソウエキスを含まないものとする。
【請求項１０】 後頭部毛髪に使用するための、請求項９に記載の薬剤。
【請求項１１】 女性患者に使用するための、請求項９または１０に記載の薬剤。
【請求項１】 女性型のアンドロゲン性脱毛症およびび慢性脱毛症を治療するためのメラトニン含有薬剤、但し、薬剤はジャコウソウエキスを含まないものとする。
【請求項２】 薬剤が局所適用可能である、請求項１に記載の薬剤。
【請求項３】 薬剤が、噴霧液、溶液、ローション剤、クリームまたは軟膏剤として適用可能である、請求項１または２に記載の薬剤。
【請求項４】 メラトニン製剤が、０．００１〜１％（重量／重量）の作用物質濃度を示す、請求項１から３までのいずれか１項に記載の薬剤。
【請求項５】 薬剤の日用量が、一日当たり０．０１〜１０ｍｇの有効量を含有する、請求項１から４までのいずれか１項に記載の薬剤。
【請求項６】 休止期の割合の減少を達成する、請求項１から５までのいずれか１項に記載の薬剤。
【請求項７】 成長期の割合の増加を達成する、請求項１から６までのいずれか１項に記載の薬剤。
【請求項８】 毛髪直径の増加および／または毛髪の引裂き力の増加が達成される、請求項１から７までのいずれか１項に記載の薬剤。
【請求項９】 び慢性脱毛症において、毛髪直径を増加させ、および／または伸長能力を増加させるためのメラトニン含有薬剤、但し、薬剤はジャコウソウエキスを含まないものとする。
【請求項１０】 後頭部毛髪に使用するための、請求項９に記載の薬剤。
【請求項１１】 女性患者に使用するための、請求項９または１０に記載の薬剤。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19957710.2 | 1999-11-30 | ||
| DE19957710A DE19957710A1 (de) | 1999-11-30 | 1999-11-30 | Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie |
| US09/506,442 US6281241B1 (en) | 1999-11-30 | 2000-02-18 | Use of melatonin for the treatment of androgenetic alopecia |
| US09/506,442 | 2000-02-18 | ||
| PCT/EP2000/011976 WO2001039771A1 (de) | 1999-11-30 | 2000-11-29 | Verwendung von melatonin zur behandlung der androgenetischen und diffusen alopezie |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004500353A JP2004500353A (ja) | 2004-01-08 |
| JP2004500353A5 true JP2004500353A5 (ja) | 2007-12-06 |
| JP4713805B2 JP4713805B2 (ja) | 2011-06-29 |
Family
ID=7930930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001541503A Expired - Fee Related JP4713805B2 (ja) | 1999-11-30 | 2000-11-29 | アンドロゲン性およびびまん性脱毛症の治療のためのメラトニンの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6281241B1 (ja) |
| EP (1) | EP1235571B1 (ja) |
| JP (1) | JP4713805B2 (ja) |
| AT (1) | ATE275400T1 (ja) |
| AU (1) | AU2838101A (ja) |
| CA (1) | CA2392620C (ja) |
| DE (2) | DE19957710A1 (ja) |
| DK (1) | DK1235571T3 (ja) |
| ES (1) | ES2228663T3 (ja) |
| PT (1) | PT1235571E (ja) |
| TR (1) | TR200402628T4 (ja) |
| WO (1) | WO2001039771A1 (ja) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19957710A1 (de) * | 1999-11-30 | 2001-05-31 | Asat Ag Applied Science & Tech | Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie |
| US6734552B2 (en) | 2001-07-11 | 2004-05-11 | Asat Limited | Enhanced thermal dissipation integrated circuit package |
| US7015072B2 (en) | 2001-07-11 | 2006-03-21 | Asat Limited | Method of manufacturing an enhanced thermal dissipation integrated circuit package |
| US6790710B2 (en) * | 2002-01-31 | 2004-09-14 | Asat Limited | Method of manufacturing an integrated circuit package |
| US20030178719A1 (en) * | 2002-03-22 | 2003-09-25 | Combs Edward G. | Enhanced thermal dissipation integrated circuit package and method of manufacturing enhanced thermal dissipation integrated circuit package |
| US6940154B2 (en) * | 2002-06-24 | 2005-09-06 | Asat Limited | Integrated circuit package and method of manufacturing the integrated circuit package |
| CN1708301A (zh) * | 2002-10-30 | 2005-12-14 | Asat应用科学技术股份公司 | 褪黑激素日剂量给药单元 |
| US20050249785A1 (en) * | 2003-08-13 | 2005-11-10 | Gordon John G | Use of melatonin-containing oral supplement with animals |
| CA2556753C (en) * | 2004-02-20 | 2014-11-25 | Lifescape Biosciences Incorporated | Compositions and methods for sleep regulation |
| JP3964417B2 (ja) * | 2004-09-27 | 2007-08-22 | 国立大学法人金沢大学 | インドール誘導体を有効成分とするα２受容体遮断剤及び血管拡張剤 |
| US20080059313A1 (en) * | 2006-08-30 | 2008-03-06 | Oblong John E | Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair |
| ITGE20070009A1 (it) * | 2007-01-24 | 2008-07-25 | Leila Baeram | Composizione cosmetica e metodo per favorire la ricrescita dei capelli. |
| US20100120871A1 (en) * | 2008-11-10 | 2010-05-13 | Dawson Jr Thomas Larry | Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair |
| GB0918564D0 (en) | 2009-10-22 | 2009-12-09 | Plasticell Ltd | Nested cell encapsulation |
| WO2011109459A2 (en) * | 2010-03-04 | 2011-09-09 | University Of Miami | Compositions, kits and methods for determining efficacy of a therapeutic agent and treating hair and skin diseases |
| ITMI20112432A1 (it) * | 2011-12-30 | 2013-07-01 | Bionest Ltd | Kit per il trattamento e la prevenzione dell'alopecia |
| US11696883B2 (en) | 2014-05-23 | 2023-07-11 | Triple Hair Inc. | Compositions for reducing hair loss and/or increasing hair regrowth |
| CN109248167A (zh) | 2014-05-23 | 2019-01-22 | 特里普海尔公司 | 用于减少脱发和/或增加毛发再生的组合物 |
| PT3347009T (pt) | 2015-07-08 | 2022-01-12 | Triple Hair Inc | Composição compreendendo resveratrol e melatonina para reduzir a perda de cabelo e/ou aumentar o crescimento do cabelo |
| CA3058484A1 (en) | 2016-04-11 | 2017-10-19 | Vytrus Biotech, S.L. | Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment |
| GB201707143D0 (en) | 2017-05-04 | 2017-06-21 | Plasticell Ltd | Method for producing cells |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5340579A (en) * | 1984-11-20 | 1994-08-23 | Farmaka S.R.L. | Method of treating dermatological conditions |
| US4746674A (en) | 1985-08-27 | 1988-05-24 | Cellena (Cell Engineering) Ag | Melatonin compositions and uses thereof |
| JPS61212512A (ja) * | 1985-03-19 | 1986-09-20 | Shiseido Co Ltd | 養毛料 |
| US4945103A (en) * | 1989-01-17 | 1990-07-31 | Michael Cohen | Method of treating pre-menstrual syndrome |
| FR2717381B1 (fr) * | 1994-03-15 | 1996-04-19 | Oreal | Compositions à base d'alpha-pyrones pour induire et stimuler la croissance des cheveux et/ou freiner leur chute et utilisation. |
| JP3108586B2 (ja) * | 1994-06-01 | 2000-11-13 | 富士産業株式会社 | 育毛剤 |
| US5597575A (en) * | 1994-06-06 | 1997-01-28 | Breitbarth; Richard | Composition for stimulating and inducing hair growth |
| DE19509354A1 (de) * | 1994-12-08 | 1996-06-13 | Klett Loch Lore M | Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall |
| US5792785A (en) * | 1995-11-24 | 1998-08-11 | Equitech Laboratories, Inc. | Method for enhancing pregnancy success in an animal |
| ES2101660B1 (es) * | 1995-12-21 | 1997-12-16 | Soler Armando Jose Yanez | Nuevo crecepelo de uso topico. |
| GB2314019B (en) * | 1996-06-10 | 2000-03-15 | Bio Scient Ltd | The use of L-Lysine in the treatment of hair loss |
| FR2751539B1 (fr) * | 1996-07-25 | 1998-12-04 | Oreal | Nouvelles compositions topiques comprenant de tres faibles doses de melatonine ou ses derives et leur utilisation en cosmetique |
| WO1998005298A1 (es) * | 1996-08-02 | 1998-02-12 | Universidad De Granada | Desarrollo de productos cosmeticos para uso humano a base de melatonina como producto activo |
| FR2754454B1 (fr) * | 1996-10-10 | 1998-11-27 | Oreal | Utilisation d'au moins un glycol comme agent de solubilisation de la melatonine dans l'eau et compositions obtenues |
| FR2756832B1 (fr) * | 1996-12-06 | 1999-01-08 | Oreal | Utilisation de melatonine dans une composition pour stabiliser les polymeres gelifiants hydrophiles |
| US5958964A (en) * | 1997-02-18 | 1999-09-28 | South Alabama Medical Science Foundation | Use of melatonin to prevent cytotoxic effects of amyloid beta protein |
| US6030948A (en) * | 1997-12-19 | 2000-02-29 | Mann; Morris A. | Hair regeneration compositions for treatment of alopecia and methods of application related thereto |
| US6274615B1 (en) * | 1998-03-25 | 2001-08-14 | South Alabama Medical Science Foundation | Method for delaying the onset of alheimer's disease and for treatment or delaying the onset of other amyloidosis-related diseases/disorders |
| DE19957710A1 (de) * | 1999-11-30 | 2001-05-31 | Asat Ag Applied Science & Tech | Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie |
| US6747008B1 (en) * | 2000-06-19 | 2004-06-08 | University Of Southern California | Methods for treating and preventing alopecia |
| FR2811550B1 (fr) * | 2000-07-11 | 2003-02-14 | Oreal | Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux |
-
1999
- 1999-11-30 DE DE19957710A patent/DE19957710A1/de not_active Ceased
-
2000
- 2000-02-18 US US09/506,442 patent/US6281241B1/en not_active Expired - Lifetime
- 2000-11-29 DE DE50007706T patent/DE50007706D1/de not_active Expired - Lifetime
- 2000-11-29 DK DK00993238T patent/DK1235571T3/da active
- 2000-11-29 PT PT00993238T patent/PT1235571E/pt unknown
- 2000-11-29 AT AT00993238T patent/ATE275400T1/de active
- 2000-11-29 WO PCT/EP2000/011976 patent/WO2001039771A1/de active Search and Examination
- 2000-11-29 US US10/130,297 patent/US20020183377A1/en not_active Abandoned
- 2000-11-29 AU AU28381/01A patent/AU2838101A/en not_active Abandoned
- 2000-11-29 CA CA002392620A patent/CA2392620C/en not_active Expired - Fee Related
- 2000-11-29 TR TR2004/02628T patent/TR200402628T4/xx unknown
- 2000-11-29 EP EP00993238A patent/EP1235571B1/de not_active Expired - Lifetime
- 2000-11-29 JP JP2001541503A patent/JP4713805B2/ja not_active Expired - Fee Related
- 2000-11-29 ES ES00993238T patent/ES2228663T3/es not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004500353A5 (ja) | ||
| US5898037A (en) | Formulations of magnesium compounds for local application and methods of treatment using the same | |
| KR100924476B1 (ko) | 국소 글리코피롤레이트 제품 | |
| US20160256366A1 (en) | Cosmetic treatment with nitric oxide, device for performing said treatment and manufacturing method therefor | |
| US5425954A (en) | Topical amino acid - vitamin complex compositions for pharmaceutical and cosmetic use | |
| JP4031513B2 (ja) | 改良された発熱性化粧品組成物 | |
| US20090214628A1 (en) | Methods and compositions for treatment of skin | |
| JP2002521320A5 (ja) | 皮膚の脂質産生を促進するための組成物 | |
| JP2002512971A5 (ja) | ||
| JP2004505007A5 (ja) | ||
| EP1948236A2 (en) | Methods and compositions for treatment of skin | |
| Weinstein | Safety, efficacy and duration of therapeutic effect of tazarotene used in the treatment of plaque psoriasis | |
| MY135988A (en) | Additive for improving the water resistance of cosmetic or dermatological formulations | |
| MXPA04000654A (es) | Terapia dermica usando derivados de fosfato de agente de transferencia de electrones. | |
| WO1998020852A1 (en) | Pharmaceutical compositions containing kukui nut oil | |
| KR20060127920A (ko) | 연마감 없는 박피 시스템 | |
| JP2006513255A (ja) | メラトニン、イチョウおよびビオチンを含有する調製物 | |
| WO2011119247A2 (en) | Topical skincare composition | |
| EP1242009B1 (en) | Tissue sensitizing compounds for females with methods and apparatus for the delivery of these compounds | |
| AR015744A1 (es) | Uso de dexmedetomidina para sedacion en terapia intensiva | |
| JP2004501939A5 (ja) | ||
| US6465514B1 (en) | Methods and compositions for the promotion of hair growth | |
| AU2005262354B2 (en) | Cosmetic compositions and methods for sensory cooling | |
| CN110769817A (zh) | 皮肤治疗方法、含类视黄醇的组合物及其递送系统 | |
| US6702733B1 (en) | Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds |